Cigna Group $CI Shares Acquired by Wealth Enhancement Advisory Services LLC

Wealth Enhancement Advisory Services LLC lifted its holdings in Cigna Group (NYSE:CI) by 4.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 95,023 shares of the health services provider’s stock after acquiring an additional 4,394 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Cigna Group were worth $27,068,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Dodge & Cox grew its position in Cigna Group by 4.0% during the 3rd quarter. Dodge & Cox now owns 9,305,225 shares of the health services provider’s stock worth $2,682,231,000 after purchasing an additional 354,615 shares during the period. Sanders Capital LLC grew its holdings in Cigna Group by 0.5% during the third quarter. Sanders Capital LLC now owns 7,828,168 shares of the health services provider’s stock worth $2,256,469,000 after acquiring an additional 35,150 shares during the period. Norges Bank purchased a new position in Cigna Group during the second quarter valued at approximately $1,110,426,000. Capital Research Global Investors raised its position in Cigna Group by 140.2% during the third quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock valued at $916,434,000 after acquiring an additional 1,855,897 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership raised its position in Cigna Group by 7.4% during the third quarter. Arrowstreet Capital Limited Partnership now owns 2,695,620 shares of the health services provider’s stock valued at $777,012,000 after acquiring an additional 186,880 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Activity

In other Cigna Group news, insider Everett Neville sold 1,719 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the sale, the insider directly owned 5,670 shares in the company, valued at approximately $1,638,119.70. The trade was a 23.26% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Nicole S. Jones sold 2,307 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the transaction, the insider owned 32,647 shares in the company, valued at approximately $9,432,044.77. This trade represents a 6.60% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.60% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have commented on the company. Barclays lowered their price objective on Cigna Group from $305.00 to $303.00 and set an “overweight” rating on the stock in a research report on Friday, February 6th. Jefferies Financial Group boosted their target price on shares of Cigna Group from $310.00 to $333.00 and gave the company a “buy” rating in a research note on Monday, February 9th. Zacks Research upgraded shares of Cigna Group from a “strong sell” rating to a “hold” rating in a research report on Monday, January 5th. Leerink Partners increased their target price on shares of Cigna Group from $270.00 to $297.00 and gave the stock a “market perform” rating in a research note on Friday, February 6th. Finally, Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, February 7th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $333.11.

Cigna Group Price Performance

Shares of NYSE CI opened at $265.78 on Wednesday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.74 and a current ratio of 0.74. The firm has a fifty day moving average of $277.46 and a 200 day moving average of $280.87. The firm has a market cap of $70.04 billion, a PE ratio of 11.98, a PEG ratio of 0.91 and a beta of 0.27. Cigna Group has a one year low of $239.51 and a one year high of $350.00.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The business had revenue of $72.50 billion for the quarter, compared to the consensus estimate of $69.53 billion. During the same period last year, the firm posted $6.64 earnings per share. The company’s revenue was up 10.4% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, research analysts predict that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, March 19th. Investors of record on Thursday, March 5th were paid a $1.56 dividend. The ex-dividend date of this dividend was Thursday, March 5th. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s dividend payout ratio is 28.13%.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.